These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 23710910)

  • 1. [The breast stem cell (CK5/6(+)) concept and its relation to the diagnosis of benign and malignant ductal epithelial hyperplasia].
    Huang SF
    Zhonghua Bing Li Xue Za Zhi; 2013 Feb; 42(2):73-7. PubMed ID: 23710910
    [No Abstract]   [Full Text] [Related]  

  • 2. [Value of CK5/6, CK14, ER and PR detection in differential diagnosis of intraductal proliferative lesions of the breast].
    Niu F; Wang L; Zhang W; Lyu S; Niu Y
    Zhonghua Zhong Liu Za Zhi; 2015 Oct; 37(10):749-52. PubMed ID: 26813593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bilateral cribriform ductal proliferation in the male breast; a mimicker of female cribriform atypical ductal hyperplasia?
    Wang Y; Zhu C; Whitney K
    Histopathology; 2011 Jul; 59(1):148-50. PubMed ID: 21771033
    [No Abstract]   [Full Text] [Related]  

  • 4. [Papillary lesions of the breast].
    Ni YB; Tse GM
    Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):721-6. PubMed ID: 24447546
    [No Abstract]   [Full Text] [Related]  

  • 5. Usual ductal hyperplasia of the breast is a committed stem (progenitor) cell lesion distinct from atypical ductal hyperplasia and ductal carcinoma in situ.
    Boecker W; Moll R; Dervan P; Buerger H; Poremba C; Diallo RI; Herbst H; Schmidt A; Lerch MM; Buchwalow IB
    J Pathol; 2002 Dec; 198(4):458-67. PubMed ID: 12434415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinicopathologic features of cystic hypersecretory lesion of the breast].
    Bi R; Cheng Y; Yu B; Shui R; Yang W; Xu X
    Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):25-9. PubMed ID: 24713245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Papillary Lesions of the Breast: A Practical Approach to Diagnosis.
    Jorns JM
    Arch Pathol Lab Med; 2016 Oct; 140(10):1052-9. PubMed ID: 27684976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnosis and management of pre-invasive breast disease: ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH)--current definitions and classification.
    Pinder SE; Ellis IO
    Breast Cancer Res; 2003; 5(5):254-7. PubMed ID: 12927035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of cytokeratin 5/6 and high-molecular-weight keratin in evaluation of cauterized surgical margins in excised specimens of breast ductal carcinoma in situ.
    Nayak A; Bhuiya TA
    Ann Diagn Pathol; 2011 Aug; 15(4):243-9. PubMed ID: 21420886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid papillary ductal carcinoma in situ versus usual ductal hyperplasia in the breast: a potentially difficult distinction resolved by cytokeratin 5/6.
    Rabban JT; Koerner FC; Lerwill MF
    Hum Pathol; 2006 Jul; 37(7):787-93. PubMed ID: 16784976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Procedures of analytic morphometry in the monitoring of nuclear changes of breast ductal epithelium from normal to carcinoma].
    Giardina C; Serio G; Potente F; Pennella A; Lettini T; Di Tolve P; Ricco R; Pesce Delfino V
    Pathologica; 1992; 84(1094):97-100. PubMed ID: 1338654
    [No Abstract]   [Full Text] [Related]  

  • 12. [Morphometric analysis of fibrocystic breast disease].
    Guski H; Freitag A; Hufnagl P; Voss K; Wenzelides K; Simon H
    Zentralbl Allg Pathol; 1986; 132(4):293-300. PubMed ID: 3026118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Well differentiated clinging carcinoma and atypical ductal hyperplasia are synonymous.
    Eusebi V; Mignani S; Koerner F; Oyama T
    Breast Cancer; 2001; 8(4):283-4. PubMed ID: 11791118
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinicopathologic and immunohistochemical study of 187 cases of intraductal papillary neoplasm of breast].
    Zhang H; Xiong Y; Zhang S; Zhang Y; Wang YH; Li T
    Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):726-31. PubMed ID: 22336153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined evaluation of CK5/6, ER, p63, and MUC3 for distinguishing breast intraductal papilloma from ductal carcinoma in situ.
    Furuya C; Kawano H; Yamanouchi T; Oga A; Ueda J; Takahashi M
    Pathol Int; 2012 Jun; 62(6):381-90. PubMed ID: 22612506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Usual hyperplasia, atypical hyperplasia and carcinoma-in-situ of breast: a morphologic study].
    Kan X; Shen DH; Shi B; He JS
    Zhonghua Bing Li Xue Za Zhi; 2004 Aug; 33(4):312-5. PubMed ID: 15363313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis of 14-3-3 sigma and related proteins in hyperplastic and neoplastic breast lesions, with particular reference to early carcinogenesis.
    Simooka H; Oyama T; Sano T; Horiguchi J; Nakajima T
    Pathol Int; 2004 Aug; 54(8):595-602. PubMed ID: 15260850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotaxic fine needle aspiration cytology of clinically occult malignant and premalignant breast lesions.
    Bibbo M; Scheiber M; Cajulis R; Keebler CM; Wied GL; Dowlatshahi K
    Acta Cytol; 1988; 32(2):193-201. PubMed ID: 2831687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Definition of precancerous and high-risk mammary lesions.
    Bégin LR
    Can J Surg; 1985 May; 28(3):248-51. PubMed ID: 2986807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with upgrading to malignancy at surgery of atypical ductal hyperplasia diagnosed on core biopsy.
    Deshaies I; Provencher L; Jacob S; Côté G; Robert J; Desbiens C; Poirier B; Hogue JC; Vachon E; Diorio C
    Breast; 2011 Feb; 20(1):50-5. PubMed ID: 20619647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.